Maglax



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 24.7%
Constipation 13.3%
Neoplasm Malignant 8.2%
Acute Coronary Syndrome 6.5%
Drug Use For Unknown Indication 5.7%
Insomnia 5.4%
Cancer Pain 3.9%
Drug Exposure During Pregnancy 3.6%
Gastric Cancer 3.2%
Cough 2.9%
Dementia With Lewy Bodies 2.9%
Depression 2.9%
Prophylaxis 2.9%
Cataract 2.2%
Diabetes Mellitus 2.2%
Gastrooesophageal Reflux Disease 2.2%
Parkinson's Disease 2.2%
Pulmonary Arterial Hypertension 2.2%
Osteoporosis 1.8%
Antiplatelet Therapy 1.4%
Pleurisy 12.1%
Osteomyelitis 9.1%
Rash 9.1%
Grand Mal Convulsion 6.1%
Lung Neoplasm Malignant 6.1%
Neutrophil Count Decreased 6.1%
Pyrexia 6.1%
Subarachnoid Haemorrhage 6.1%
Vomiting 6.1%
Aplasia Pure Red Cell 3.0%
Cholecystitis Acute 3.0%
Deep Vein Thrombosis 3.0%
Drug Rash With Eosinophilia And Systemic Symptoms 3.0%
Drug Withdrawal Syndrome Neonatal 3.0%
Ileus Paralytic 3.0%
Intestinal Ischaemia 3.0%
Lymphocyte Stimulation Test Positive 3.0%
Malaise 3.0%
Oedema Peripheral 3.0%
Platelet Count Decreased 3.0%
Concomitant
Prophylaxis 15.3%
Constipation 13.0%
Product Used For Unknown Indication 11.0%
Hypertension 9.6%
Drug Use For Unknown Indication 8.6%
Cancer Pain 5.3%
Rheumatoid Arthritis 4.7%
Insomnia 4.5%
Pain 3.9%
Multiple Myeloma 3.7%
Diabetes Mellitus 3.0%
Gastritis 2.8%
Parkinson's Disease 2.6%
Depression 2.2%
Schizophrenia 1.9%
Metastases To Bone 1.7%
Gastric Ulcer 1.6%
Hepatitis C 1.6%
Osteoporosis 1.5%
Chronic Hepatitis C 1.5%
White Blood Cell Count Decreased 15.3%
Pyrexia 10.2%
Interstitial Lung Disease 9.4%
Rash 8.1%
Vomiting 6.0%
White Blood Cell Count Increased 5.7%
Pneumonia 5.5%
Platelet Count Decreased 4.0%
Renal Impairment 4.0%
Stomatitis 3.6%
Liver Disorder 3.1%
Pleural Effusion 3.1%
Somnolence 3.1%
Weight Decreased 3.1%
Palmar-plantar Erythrodysaesthesia Syndrome 2.8%
Sepsis 2.7%
Neutrophil Count Decreased 2.5%
Respiratory Failure 2.5%
Hepatic Function Abnormal 2.4%
Renal Failure Acute 2.4%
Interacting
Insomnia 33.3%
Constipation 16.7%
Dementia 16.7%
Depression 16.7%
Dyslipidaemia 16.7%
Drug Interaction 100.0%